- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) in United Kingdom
Total 2430 results
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands
-
ITM Solucin GmbHABX CRO; PSI CROActive, not recruitingNeuroendocrine TumorsGermany, France, United States, United Kingdom, Australia, Italy, Belgium, Switzerland, Czechia, Spain, Austria, Netherlands, Poland, South Africa
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)France, Spain, Belgium, Germany, Italy, United Kingdom, Netherlands
-
Centocor, Inc.Janssen-Cilag Farmaceutica, S.R.L.CompletedMelanomaUnited States, United Kingdom, Germany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Gastric Adenocarcinoma | Pancreatic Neuroendocrine CarcinomaUnited States
-
Columbia UniversityCompleted
-
National Cancer Institute (NCI)CompletedPancreatic Neuroendocrine Carcinoma | Multiple Endocrine Neoplasia Type 1United States
-
Memorial Sloan Kettering Cancer CenterRecruitingMelanoma | Head and Neck Cancer | Gynecologic Cancer | Thoracic Cancer | Head and Neck Tumor | Gynecologic Tumor | Thoracic TumorUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRegeneron Pharmaceuticals; Sanofi-SynthelaboRecruitingMerkel Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Italy, United Kingdom, Netherlands, Canada, Germany, Australia, Spain, Switzerland, France
-
Shaheen ShaguftaNational Cancer Institute (NCI)CompletedRecurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Gastrinoma | Glucagonoma | Insulinoma | Pancreatic Polypeptide Tumor | Recurrent Islet Cell Carcinoma | SomatostatinomaUnited States
-
National Cancer Institute (NCI)CompletedGastrinoma | Glucagonoma | Insulinoma | Metastatic Gastrointestinal Carcinoid Tumor | Pancreatic Polypeptide Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | WDHA SyndromeUnited States
-
Robert RamirezAadi Bioscience, Inc.Terminated
-
National Cancer Institute (NCI)CompletedStage IV Uveal Melanoma AJCC v7 | Recurrent Uveal MelanomaUnited States, France, United Kingdom
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Providence Health & ServicesExelixis; Advanced Accelerator Applications SAActive, not recruitingNeuroendocrine TumorsUnited States
-
University of Wisconsin, MadisonNovartis PharmaceuticalsTerminated
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedNeuroendocrine TumorsUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...Completed
-
University of Vermont Medical CenterUnknownLung Carcinoid Tumor | Stage IA Non-small Cell Lung CancerUnited States
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
Grupo Espanol de Tumores NeuroendocrinosNovartis Pharmaceuticals; European Neuroendocrine Tumor Society; Kantar HealthCompletedNeuroendocrine TumorsSpain, United Kingdom, Denmark, France, Netherlands, Germany, Italy, Sweden
-
AstraZenecaCompletedMelanomaSweden, United States, Brazil, Czech Republic, France, Spain, United Kingdom, Germany, Norway, Hungary, Netherlands, Switzerland
-
Molecular Targeting Technologies, Inc.ClinSmartRecruitingNeuroendocrine TumorsUnited States
-
Lowell Anthony, MDTerSera Therapeutics LLCTerminated
-
Radiomedix, Inc.CompletedNeuroendocrine TumorsUnited States
-
Pamela L. KunzCompletedPhase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine TumorsNeuroendocrine TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterNo longer availableNeuroendocrine TumorsUnited States
-
University of California, San FranciscoGenentech, Inc.; Novartis Pharmaceuticals; The V Foundation for Cancer ResearchTerminated
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingGastric Neuroendocrine Carcinoma | Intestinal Neuroendocrine Carcinoma | Pancreatic Neuroendocrine CarcinomaUnited States
-
Columbia UniversityRecruitingUveal MelanomaUnited States, Australia, Canada, Germany, United Kingdom
-
Eisai Inc.CompletedMetastatic MelanomaUnited States, Australia, United Kingdom, Germany
-
University of Michigan Rogel Cancer CenterRecruitingNeuroendocrine TumorsUnited States
-
Dwight OwenBristol-Myers SquibbActive, not recruitingNeuroendocrine Tumors | Small-cell Lung Cancer | Neuroendocrine Carcinoma | Large Cell Neuroendocrine Carcinoma | Lung Cancer Stage IV | Recurrent Small Cell Lung Carcinoma | Refractory Small Cell Lung Carcinoma | Metastatic Neuroendocrine Carcinoma | Grade I Neuroendocrine Carcinoma | Grade II Neuroendocrine... and other conditionsUnited States
-
O'Dorisio, M SNational Cancer Institute (NCI)CompletedSarcoma | Unspecified Childhood Solid Tumor, Protocol Specific | Brain and Central Nervous System Tumors | Neuroblastoma | Pheochromocytoma | Islet Cell Tumor | Gastrointestinal Carcinoid TumorUnited States
-
Fox Chase Cancer CenterMerck Sharp & Dohme LLCCompleted
-
PfizerTerminatedMetastatic Pancreatic Adenocarcinoma | BRAF Mutated MelanomaUnited States, Australia, Belgium, Canada, France, Italy, Spain, United Kingdom
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnEwing Sarcoma of Bone | Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor | Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Adult Supratentorial Primitive Neuroectodermal Tumor (PNET) and other conditionsUnited States
-
AstraZenecaCompletedMelanomaUnited States, Australia, Brazil, United Kingdom, Argentina, Austria, Canada, Denmark, France, Switzerland
-
National Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation | Metastatic Prostate Neuroendocrine CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterNeuroEndocrine Tumor Research Foundation (NETRF)RecruitingNeuroendocrine TumorsUnited States
-
Methodist Health SystemRecruitingNeuroendocrine TumorsUnited States
-
Ebrahim S DelpassandExcel Diagnostics and Nuclear Oncology CenterCompletedNeuroendocrine TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedNeuroendocrine TumorsUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Shanghai EpimAb Biotherapeutics Co., Ltd.Labcorp Corporation of America Holdings, IncRecruitingNeoplasms | Neoplasm Metastasis | Metastatic Gastrointestinal Carcinoid TumorUnited States, China
-
Delcath Systems Inc.IQVIA BiotechCompletedMelanoma, OcularUnited States, Spain, Italy, Germany, United Kingdom, Switzerland, Belgium, Austria, France
-
PharmaMarCompletedNeuroendocrine Tumors | Endometrial Adenocarcinomas | Small-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of TherapySpain, United Kingdom
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute Australia; Cancer Council New South WalesActive, not recruitingMetastatic Melanoma to the Groin Lymph NodesUnited Kingdom, Slovenia, Australia, Brazil, Netherlands, Italy